Wall Street expects Hawkins to report fiscal second-quarter revenue of $302.70 million and EPS of $1.19, with shares trading at $133.17 against a consensus price target of $170.50. Investors are primarily focused on the growth and margin profile of the Water Treatment segment following the recent strategic acquisitions of Eagle Labs and Dave Symonds.
The company aims to reverse a four-quarter streak of earnings misses attributed to elevated amortization and interest costs associated with its aggressive M&A expansion. Analysts will be looking for evidence that organic volume gains and cost synergies in its chemical distribution network are beginning to offset pricing volatility in the broader specialty chemicals market.